Confirmation of the cellular targets of benomyl and rapamycin using next-generation sequencing of resistant mutants in S. cerevisiae

Molecular BioSystems

Volumn 10, Issue 12, 2014, Pages 3179-3187

  Wride, Dustin A ^a   Pourmand, Nader ^b   Bray, Walter M ^a   Kosarchuk, Jacob J ^a   Nisam, Sean C ^a   Quan, Tiffani K ^a   Berkeley, Ray F ^a   Katzman, Sol ^b   Hartzog, Grant A ^a   Dobkin, Carlos E ^a   Scott Lokey, R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California Santa Cruz   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENOMYL; DNA BINDING PROTEIN; FUNGAL DNA; PDR1 PROTEIN, S CEREVISIAE; RAPAMYCIN; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSCRIPTION FACTOR; TUB2 PROTEIN, S CEREVISIAE;

DNA SEQUENCE; DRUG EFFECTS; GENE DELETION; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MULTIDRUG RESISTANCE; PROCEDURES; SACCHAROMYCES CEREVISIAE; SINGLE NUCLEOTIDE POLYMORPHISM;

BENOMYL; DNA, FUNGAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE, FUNGAL; GENE DELETION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; POLYMORPHISM, SINGLE NUCLEOTIDE; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE ANALYSIS, DNA; SIROLIMUS; TRANSCRIPTION FACTORS;

EID: 84908406054     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c4mb00146j     Document Type: Article

References (40)

1. D. C. Swinney J. Anthony How were new medicines discovered? Nat. Rev. Drug Discovery 2011 10 7 507 519
2. S. A. Wacker B. R. Houghtaling O. Elemento T. M. Kapoor Using transcriptome sequencing to identify mechanisms of drug action and resistance Nat. Chem. Biol. 2012 8 3 235 237
3. B. Lomenick R. Hao N. Jonai R. M. Chin M. Aghajan S. Warburton J. Wang R. P. Wu F. Gomez J. A. Loo J. A. Wohlschlegel T. M. Vondriska J. Pelletier H. R. Herschman J. Clardy C. F. Clarke J. Huang Target identification using drug affinity responsive target stability (DARTS) Proc. Natl. Acad. Sci. U. S. A. 2009 106 51 21984 21989
4. M. Menacho-Marquez J. R. Murguia Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research Clin. Transl. Oncol. 2007 9 4 221 228
5. A. Lopez A. B. Parsons C. Nislow G. Giaever C. Boone Chemical-genetic approaches for exploring the mode of action of natural products Prog. Drug Res. 2008 66 237
6. G. Giaever D. D. Shoemaker T. W. Jones H. Liang E. A. Winzeler A. Astromoff R. W. Davis Genomic profiling of drug sensitivities via induced haploinsufficiency Nat. Genet. 1999 21 3 278 283
7. G. Giaever A. M. Chu L. Ni C. Connelly L. Riles S. Veronneau S. Dow A. Lucau-Danila K. Anderson B. Andre A. P. Arkin A. Astromoff M. El-Bakkoury R. Bangham R. Benito S. Brachat S. Campanaro M. Curtiss K. Davis A. Deutschbauer K. D. Entian P. Flaherty F. Foury D. J. Garfinkel M. Gerstein D. Gotte U. Guldener J. H. Hegemann S. Hempel Z. Herman D. F. Jaramillo D. E. Kelly S. L. Kelly P. Kotter D. LaBonte D. C. Lamb N. Lan H. Liang H. Liao L. Liu C. Luo M. Lussier R. Mao P. Menard S. L. Ooi J. L. Revuelta C. J. Roberts M. Rose P. Ross-Macdonald B. Scherens G. Schimmack B. Shafer D. D. Shoemaker S. Sookhai-Mahadeo R. K. Storms J. N. Strathern G. Valle M. Voet G. Volckaert C. Y. Wang T. R. Ward J. Wilhelmy E. A. Winzeler Y. Yang G. Yen E. Youngman K. Yu H. Bussey J. D. Boeke M. Snyder P. Philippsen R. W. Davis M. Johnston Functional profiling of the Saccharomyces cerevisiae genome Nature 2002 418 6896 387 391
8. A. B. Parsons A. Lopez I. E. Givoni D. E. Williams C. A. Gray J. Porter G. Chua R. Sopko R. L. Brost C. H. Ho J. Wang T. Ketela C. Brenner J. A. Brill G. E. Fernandez T. C. Lorenz G. S. Payne S. Ishihara Y. Ohya B. Andrews T. R. Hughes B. J. Frey T. R. Graham R. J. Andersen C. Boone Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast Cell 2006 126 3 611 625
9. S. Hoon A. M. Smith I. M. Wallace S. Suresh M. Miranda E. Fung M. Proctor K. M. Shokat C. Zhang R. W. Davis G. Giaever R. P. St Onge C. Nislow An integrated platform of genomic assays reveals small-molecule bioactivities Nat. Chem. Biol. 2008 4 8 498 506
10. H. Luesch T. Y. Wu P. Ren N. S. Gray P. G. Schultz F. Supek A genome-wide overexpression screen in yeast for small-molecule target identification Chem. Biol. 2005 12 1 55 63
11. R. A. Butcher S. L. Schreiber A small molecule suppressor of FK506 that targets the mitochondria and modulates ionic balance in Saccharomyces cerevisiae Chem. Biol. 2003 10 6 521 531
12. C. H. Ho L. Magtanong S. L. Barker D. Gresham S. Nishimura P. Natarajan J. L. Koh J. Porter C. A. Gray R. J. Andersen G. Giaever C. Nislow B. Andrews D. Botstein T. R. Graham M. Yoshida C. Boone A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds Nat. Biotechnol. 2009 27 4 369 377
13. Z. Huang K. Chen J. Zhang Y. Li H. Wang D. Cui J. Tang Y. Liu X. Shi W. Li D. Liu R. Chen R. S. Sucgang X. Pan A functional variomics tool for discovering drug-resistance genes and drug targets Cell Rep. 2013 3 2 577 585
14. P. Y. Lum C. D. Armour S. B. Stepaniants G. Cavet M. K. Wolf J. S. Butler J. C. Hinshaw P. Garnier G. D. Prestwich A. Leonardson P. Garrett-Engele C. M. Rush M. Bard G. Schimmack J. W. Phillips C. J. Roberts D. D. Shoemaker Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes Cell 2004 116 1 121 137
15. J. Heitman N. R. Movva M. N. Hall Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast Science 1991 253 5022 905 909
16. R. Cafferkey P. R. Young M. M. McLaughlin D. J. Bergsma Y. Koltin G. M. Sathe L. Faucette W. K. Eng R. K. Johnson G. P. Livi Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity Mol. Cell. Biol. 1993 13 10 6012 6023
17. J. Kunz R. Henriquez U. Schneider M. Deuter-Reinhard N. R. Movva M. N. Hall Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression Cell 1993 73 3 585 596
18. E. J. Brown M. W. Albers T. B. Shin K. Ichikawa C. T. Keith W. S. Lane S. L. Schreiber A mammalian protein targeted by G1-arresting rapamycin-receptor complex Nature 1994 369 6483 756 758
19. J. Inokoshi H. Tomoda H. Hashimoto A. Watanabe H. Takeshima S. Omura Cerulenin-resistant mutants of Saccharomyces cerevisiae with an altered fatty acid synthase gene Mol. Gen. Genet. 1994 244 1 90 96
20. L. Wu J. Pan V. Thoroddsen D. R. Wysong R. K. Blackman C. E. Bulawa A. E. Gould T. D. Ocain L. R. Dick P. Errada P. K. Dorr T. Parkinson T. Wood D. Kornitzer Z. Weissman I. M. Willis K. McGovern Novel small-molecule inhibitors of RNA polymerase III Eukaryotic Cell 2003 2 2 256 264
21. G. Gustafson G. Davis C. Waldron A. Smith M. Henry Identification of a new antifungal target site through a dual biochemical and molecular-genetics approach Curr. Genet. 1996 30 2 159 165
22. K. Andries P. Verhasselt J. Guillemont H. W. Gohlmann J. M. Neefs H. Winkler J. Van Gestel P. Timmerman M. Zhu E. Lee P. Williams D. de Chaffoy E. Huitric S. Hoffner E. Cambau C. Truffot-Pernot N. Lounis V. Jarlier A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis Science 2005 307 5707 223 227
23. S. D. Singh-Babak T. Babak S. Diezmann J. A. Hill J. L. Xie Y. L. Chen S. M. Poutanen R. P. Rennie J. Heitman L. E. Cowen Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata PLoS Pathog. 2012 8 5 e1002718
24. B. Timmermann S. Jarolim H. Russmayer M. Kerick S. Michel A. Kruger K. Bluemlein P. Laun J. Grillari H. Lehrach M. Breitenbach M. Ralser A new dominant peroxiredoxin allele identified by whole-genome re-sequencing of random mutagenized yeast causes oxidant-resistance and premature aging Aging 2010 2 8 475 486
25. C. B. Brachmann A. Davies G. J. Cost E. Caputo J. Li P. Hieter J. D. Boeke Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications Yeast 1998 14 2 115 132
26. M. H. Woehrmann N. C. Gassner W. M. Bray J. M. Stuart S. Lokey HALO384: a halo-based potency prediction algorithm for high-throughput detection of antimicrobial agents J. Biomol. Screening 2010 15 2 196 205
27. B. Langmead S. L. Salzberg Fast gapped-read alignment with Bowtie 2 Nat. Methods 2012 9 4 357 359
28. A. McKenna M. Hanna E. Banks A. Sivachenko K. Cibulskis A. Kernytsky K. Garimella D. Altshuler S. Gabriel M. Daly M. A. DePristo The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data Genome Res. 2010 20 9 1297 1303
29. M. A. DePristo E. Banks R. Poplin K. V. Garimella J. R. Maguire C. Hartl A. A. Philippakis G. del Angel M. A. Rivas M. Hanna A. McKenna T. J. Fennell A. M. Kernytsky A. Y. Sivachenko K. Cibulskis S. B. Gabriel D. Altshuler M. J. Daly A framework for variation discovery and genotyping using next-generation DNA sequencing data Nat. Genet. 2011 43 5 491 498
30. N. C. Gassner C. M. Tamble J. E. Bock N. Cotton K. N. White K. Tenney R. P. St Onge M. J. Proctor G. Giaever C. Nislow R. W. Davis P. Crews T. R. Holman R. S. Lokey Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay J. Nat. Prod. 2007 70 3 383 390
31. E. Carvajal H. B. van den Hazel A. Cybularz-Kolaczkowska E. Balzi A. Goffeau Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes Mol. Gen. Genet. 1997 256 4 406 415
32. E. Balzi A. Goffeau Yeast multidrug resistance: the PDR network J. Bioenerg. Biomembr. 1995 27 1 71 76
33. M. H. Woehrmann N. C. Gassner W. M. Bray J. M. Stuart S. Lokey HALO384: a halo-based potency prediction algorithm for high-throughput detection of antimicrobial agents J. Biomol. Screening 2010 15 2 196 205
34. M. Lynch W. Sung K. Morris N. Coffey C. R. Landry E. B. Dopman W. J. Dickinson K. Okamoto S. Kulkarni D. L. Hartl W. K. Thomas A genome-wide view of the spectrum of spontaneous mutations in yeast Proc. Natl. Acad. Sci. U. S. A. 2008 105 27 9272 9277
35. A. C. Gerstein H. J. Chun A. Grant S. P. Otto Genomic convergence toward diploidy in Saccharomyces cerevisiae PLoS Genet. 2006 2 9 e145
36. Y. Shiwa S. Fukushima-Tanaka K. Kasahara T. Horiuchi H. Yoshikawa Whole-Genome Profiling of a Novel Mutagenesis Technique Using Proofreading-Deficient DNA Polymerase delta Int. J. Evol. Biol. 2012 2012 860797
37. J. H. Thomas N. F. Neff D. Botstein Isolation and characterization of mutations in the beta-tubulin gene of Saccharomyces cerevisiae Genetics 1985 111 4 715 734
38. G. D. Van Duyne R. F. Standaert S. L. Schreiber J. Clardy Atomic Structure of the Rapamycin Human Immunophilin FKBP-12 Complex J. Am. Chem. Soc. 1991 113 7433 7434
39. S. B. Helliwell P. Wagner J. Kunz M. Deuter-Reinhard R. Henriquez M. N. Hall TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast Mol. Biol. Cell 1994 5 1 105 118
40. M. C. Lorenz J. Heitman TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin J. Biol. Chem. 1995 270 46 27531 27537